Loading…
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands
In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine se...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2001-05, Vol.11 (9), p.1241-1243 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3 |
container_end_page | 1243 |
container_issue | 9 |
container_start_page | 1241 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 11 |
creator | BÖHME, Thomas M KEIM, Christine DANNHARDT, Gerd MUTSCHLER, Ernst LAMBRECHT, Günter |
description | In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity. |
doi_str_mv | 10.1016/S0960-894X(01)00186-X |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70863440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70863440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotn78BCUgiB5WJ02abo7iNyge7KG3MJvM1sh-tElX8N-71VJPwwzP-w48jJ0IuBIg9PU7GA1ZbtTsAsQlgMh1NtthQ6G0yqSC8S4bbpEBO0jps4cUKLXPBkLIsZK5HjJ7RynMG46N54sPjDW6tmrn37wt-bILTeeq4END3FMMX7gKX5Q4Jv46yhJV5NYHXnfJYQxNcDySo8WqjbwK874zHbG9EqtEx5t5yKYP99Pbp-zl7fH59uYlcyOVrzJjlMt1QUZpAgHKo0Mohc-xX4QzY6ORgEbSyXJSeGkKJYxD6UeovSrkITv_q13EdtlRWtk6JEdVhQ21XbITyLVUCnpw_Ae62KYUqbSLGGqM31aAXYu1v2Lt2poFYX_F2lmfO9086Iqa_H9qY7IHzjYA9jKqMmLjQtpyZtKrn8gfabmCkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70863440</pqid></control><display><type>article</type><title>Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands</title><source>Elsevier</source><creator>BÖHME, Thomas M ; KEIM, Christine ; DANNHARDT, Gerd ; MUTSCHLER, Ernst ; LAMBRECHT, Günter</creator><creatorcontrib>BÖHME, Thomas M ; KEIM, Christine ; DANNHARDT, Gerd ; MUTSCHLER, Ernst ; LAMBRECHT, Günter</creatorcontrib><description>In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(01)00186-X</identifier><identifier>PMID: 11354386</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Alzheimer Disease - diagnostic imaging ; Biological and medical sciences ; Cholinergic system ; Humans ; In Vitro Techniques ; Ligands ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Quinuclidines - chemical synthesis ; Quinuclidines - pharmacology ; Radiopharmaceuticals - chemical synthesis ; Receptor, Muscarinic M2 ; Receptors, Muscarinic - drug effects ; Tomography, Emission-Computed</subject><ispartof>Bioorganic & medicinal chemistry letters, 2001-05, Vol.11 (9), p.1241-1243</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3</citedby><cites>FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=974047$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11354386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BÖHME, Thomas M</creatorcontrib><creatorcontrib>KEIM, Christine</creatorcontrib><creatorcontrib>DANNHARDT, Gerd</creatorcontrib><creatorcontrib>MUTSCHLER, Ernst</creatorcontrib><creatorcontrib>LAMBRECHT, Günter</creatorcontrib><title>Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity.</description><subject>Alzheimer Disease - diagnostic imaging</subject><subject>Biological and medical sciences</subject><subject>Cholinergic system</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinuclidines - chemical synthesis</subject><subject>Quinuclidines - pharmacology</subject><subject>Radiopharmaceuticals - chemical synthesis</subject><subject>Receptor, Muscarinic M2</subject><subject>Receptors, Muscarinic - drug effects</subject><subject>Tomography, Emission-Computed</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMotn78BCUgiB5WJ02abo7iNyge7KG3MJvM1sh-tElX8N-71VJPwwzP-w48jJ0IuBIg9PU7GA1ZbtTsAsQlgMh1NtthQ6G0yqSC8S4bbpEBO0jps4cUKLXPBkLIsZK5HjJ7RynMG46N54sPjDW6tmrn37wt-bILTeeq4END3FMMX7gKX5Q4Jv46yhJV5NYHXnfJYQxNcDySo8WqjbwK874zHbG9EqtEx5t5yKYP99Pbp-zl7fH59uYlcyOVrzJjlMt1QUZpAgHKo0Mohc-xX4QzY6ORgEbSyXJSeGkKJYxD6UeovSrkITv_q13EdtlRWtk6JEdVhQ21XbITyLVUCnpw_Ae62KYUqbSLGGqM31aAXYu1v2Lt2poFYX_F2lmfO9086Iqa_H9qY7IHzjYA9jKqMmLjQtpyZtKrn8gfabmCkg</recordid><startdate>20010507</startdate><enddate>20010507</enddate><creator>BÖHME, Thomas M</creator><creator>KEIM, Christine</creator><creator>DANNHARDT, Gerd</creator><creator>MUTSCHLER, Ernst</creator><creator>LAMBRECHT, Günter</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010507</creationdate><title>Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands</title><author>BÖHME, Thomas M ; KEIM, Christine ; DANNHARDT, Gerd ; MUTSCHLER, Ernst ; LAMBRECHT, Günter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alzheimer Disease - diagnostic imaging</topic><topic>Biological and medical sciences</topic><topic>Cholinergic system</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinuclidines - chemical synthesis</topic><topic>Quinuclidines - pharmacology</topic><topic>Radiopharmaceuticals - chemical synthesis</topic><topic>Receptor, Muscarinic M2</topic><topic>Receptors, Muscarinic - drug effects</topic><topic>Tomography, Emission-Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BÖHME, Thomas M</creatorcontrib><creatorcontrib>KEIM, Christine</creatorcontrib><creatorcontrib>DANNHARDT, Gerd</creatorcontrib><creatorcontrib>MUTSCHLER, Ernst</creatorcontrib><creatorcontrib>LAMBRECHT, Günter</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BÖHME, Thomas M</au><au>KEIM, Christine</au><au>DANNHARDT, Gerd</au><au>MUTSCHLER, Ernst</au><au>LAMBRECHT, Günter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2001-05-07</date><risdate>2001</risdate><volume>11</volume><issue>9</issue><spage>1241</spage><epage>1243</epage><pages>1241-1243</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>11354386</pmid><doi>10.1016/S0960-894X(01)00186-X</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2001-05, Vol.11 (9), p.1241-1243 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_70863440 |
source | Elsevier |
subjects | Alzheimer Disease - diagnostic imaging Biological and medical sciences Cholinergic system Humans In Vitro Techniques Ligands Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments Quinuclidines - chemical synthesis Quinuclidines - pharmacology Radiopharmaceuticals - chemical synthesis Receptor, Muscarinic M2 Receptors, Muscarinic - drug effects Tomography, Emission-Computed |
title | Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A55%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20pharmacology%20of%20quinuclidine%20derivatives%20as%20M2-selective%20muscarinic%20receptor%20ligands&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=B%C3%96HME,%20Thomas%20M&rft.date=2001-05-07&rft.volume=11&rft.issue=9&rft.spage=1241&rft.epage=1243&rft.pages=1241-1243&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(01)00186-X&rft_dat=%3Cproquest_cross%3E70863440%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c248t-994c86be946e0104daca0f1d8a1041c9596ae0e23c3f7bd39b419ca3d2a6d4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70863440&rft_id=info:pmid/11354386&rfr_iscdi=true |